Icon (ICLR) Receivables - Accured (2018 - 2023)

Icon (ICLR) posted quarterly Receivables - Accured of $35000.0 for Q4 2023, down 5.41% quarter-over-quarter from $37000.0 in Q4 2018.

Icon (ICLR) Receivables - Accured (2018 - 2023) Analysis & Trends

Icon (ICLR) has reported Receivables - Accured for 2 consecutive years, with $35000.0 the latest figure, recorded in Q4 2023.

In Q4 2023, Receivables - Accured changed N/A year-over-year to $35000.0; the TTM figure through Dec 2023 stood at $35000.0 (changed N/A YoY), while the FY2023 annual figure was $35000.0, changed N/A from the prior year.
Receivables - Accured fell to $35000.0 in Q4 2023 per ICLR's latest filing, from $37000.0 in the prior quarter.
Across five years, Receivables - Accured topped out at $35000.0 in Q4 2023 and bottomed at $35000.0 in Q4 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables - Accured (Qtr)
1	Thermo Fisher Scientific	213.40 Bn	209.33 Bn	8.34 Bn	-
2	Danaher	139.94 Bn	135.59 Bn	3.61 Bn	-
3	Idexx Laboratories	46.03 Bn	45.83 Bn	779.09 Mn	-
4	Agilent Technologies	39.69 Bn	37.88 Bn	990.00 Mn	-
5	Iqvia Holdings	39.32 Bn	37.24 Bn	1.44 Bn	-
6	Natera	38.47 Bn	37.37 Bn	696.04 Mn	-
7	Illumina	29.98 Bn	28.82 Bn	770.00 Mn	-
8	Mettler Toledo International	28.57 Bn	28.52 Bn	650.22 Mn	-
9	Quest Diagnostics	26.21 Bn	25.58 Bn	1.03 Bn	-
10	Icon	12.60 Bn	12.60 Bn	479.29 Mn	-

Download Data